The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
(1972) · New England Journal of Medicine · doi:10.1056/nejm197210192871623 · Cited by 928
Nauseef, W. M., & Borregaard, N. (2014) · Nature Immunology · doi:10.1038/ni.2921 · Cited by 892
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Korkmaz, B., Horwitz, M. S., Jenne, D. E., & Gauthier, F. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002733 · Cited by 870
A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia
Button, B., Cai, L.-H., Ehre, C., Kesimer, M., Hill, D. B., Sheehan, J. K., Boucher, R. C., & Rubinstein, M. (2012) · Science · doi:10.1126/science.1223012 · Cited by 863
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
Pezzulo, A. A., Tang, X. X., Hoegger, M. J., Abou Alaiwa, M. H., Ramachandran, S., Moninger, T. O., Karp, P. H., Wohlford-Lenane, C. L., Haagsman, H. P., van Eijk, M., et al. (2012) · Nature · doi:10.1038/nature11130 · Cited by 808
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
Konstan, M. W., Byard, P. J., Hoppel, C. L., & Davis, P. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321303 · Cited by 726
Self-citationCystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Mueller, G., Hadjiliadis, D., Hoag, J. B., Lubsch, L., Hazle, L., Sabadosa, K., Marshall, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1160oe · Cited by 615
Risk Factors for Bronchiectasis in Children with Cystic Fibrosis
Sly, P. D., Gangell, C. L., Chen, L., Ware, R. S., Ranganathan, S., Mott, L. S., Murray, C. P., & Stick, S. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301725 · Cited by 595
Teichgräber, V., Ulrich, M., Endlich, N., Riethmüller, J., Wilker, B., De Oliveira–Munding, C. C., van Heeckeren, A. M., Barr, M. L., von Kürthy, G., Schmid, K. W., et al. (2008) · Nature Medicine · doi:10.1038/nm1748 · Cited by 542
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts
Grassmé, H., Jendrossek, V., Riehle, A., von Kürthy, G., Berger, J., Schwarz, H., Weller, M., Kolesnick, R., & Gulbins, E. (2003) · Nature Medicine · doi:10.1038/nm823 · Cited by 536
Airway Surface Dehydration in Cystic Fibrosis: Pathogenesis and Therapy
Boucher, R. C. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.071905.105316 · Cited by 512
Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth
Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S., Rogan, M. P., Davis, G. J., Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000928 · Cited by 495
Rowe, S. M., Heltshe, S. L., Gonska, T., Donaldson, S. H., Borowitz, D., Gelfond, D., Sagel, S. D., Khan, U., Mayer-Hamblett, N., Van Dalfsen, J. M., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0703oc · Cited by 492
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz, R. M., Schidlow, D. V., Wilmott, R. W., Astley, S. J., McBurnie, M. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282403 · Cited by 458
Poulsen, J. H., Fischer, H., Illek, B., & Machen, T. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5340 · Cited by 420
Systemic deficiency of glutathione in cystic fibrosis
Roum, J. H., Buhl, R., McElvaney, N. G., Borok, Z., & Crystal, R. G. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.6.2419 · Cited by 399
McAllister, F., Henry, A., Kreindler, J. L., Dubin, P. J., Ulrich, L., Steele, C., Finder, J. D., Pilewski, J. M., Carreno, B. M., Goldman, S. J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.404 · Cited by 398
Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism
Freedman, S. D., Blanco, P. G., Zaman, M. M., Shea, J. C., Ollero, M., Hopper, I. K., Weed, D. A., Gelrud, A., Regan, M. M., Laposata, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021218 · Cited by 395
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13572 · Cited by 373
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis
Hoegger, M. J., Fischer, A. J., McMenimen, J. D., Ostedgaard, L. S., Tucker, A. J., Awadalla, M. A., Moninger, T. O., Michalski, A. S., Hoffman, E. A., Zabner, J., et al. (2014) · Science · doi:10.1126/science.1255825 · Cited by 368
Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients
MUHLEBACH, M. S., STEWART, P. W., LEIGH, M. W., & NOAH, T. L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9808096 · Cited by 354
Gustafsson, J. K., Ermund, A., Ambort, D., Johansson, M. E. V., Nilsson, H. E., Thorell, K., Hebert, H., Sjövall, H., & Hansson, G. C. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120562 · Cited by 345
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis
Eigen, H., Rosenstein, B. J., FitzSimmons, S., & Schidlow, D. V. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70343-8 · Cited by 344
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213572 · Cited by 327
Gaggar, A., Jackson, P. L., Noerager, B. D., O’Reilly, P. J., McQuaid, D. B., Rowe, S. M., Clancy, J. P., & Blalock, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5662 · Cited by 325
Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease
Hartl, D., Latzin, P., Hordijk, P., Marcos, V., Rudolph, C., Woischnik, M., Krauss-Etschmann, S., Koller, B., Reinhardt, D., Roscher, A. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1690 · Cited by 322
Self-citationSommerhoff, C. P., Nadel, J. A., Basbaum, C. B., & Caughey, G. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114492 · Cited by 318
ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
Auerbach, H., Kirkpatrick, J., Williams, M., & Colten, H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92929-0 · Cited by 302
McElvaney, N. G., Nakamura, H., Birrer, P., Hébert, C. A., Wong, W. L., Alphonso, M., Baker, J. B., Catalano, M. A., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115994 · Cited by 299
EXPENDITURE ON N.H.S. PRACTICE PREMISES. THE MINISTER'S LETTER.
Barber, A. C. (1964) · PubMed · Cited by 293
Tosi, M. F., Zakem, H., & Berger, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114699 · Cited by 289
Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium
Coakley, R. D., Grubb, B. R., Paradiso, A. M., Gatzy, J. T., Johnson, L. G., Kreda, S. M., O'Neal, W. K., & Boucher, R. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634339100 · Cited by 287
Garcia, M. A. S., Yang, N., & Quinton, P. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38662 · Cited by 287
Glutathione permeability of CFTR
Linsdell, P., & Hanrahan, J. W. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.1.c323 · Cited by 283
Cystic Fibrosis Transmembrane Conductance Regulator Function Is Suppressed in Cigarette Smokers
Cantin, A. M., Hanrahan, J. W., Bilodeau, G., Ellis, L., Dupuis, A., Liao, J., Zielenski, J., & Durie, P. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1330oc · Cited by 280
Self-citationNeutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells
Voynow, J. A., Young, L. R., Wang, Y., Horger, T., Rose, M. C., & Fischer, B. M. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l835 · Cited by 280
CFTR: cystic fibrosis and beyond
Mall, M. A., & Hartl, D. (2014) · European Respiratory Journal · doi:10.1183/09031936.00228013 · Cited by 259
Self-citationKelley, T. J., & Drumm, M. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2357 · Cited by 255
An overview of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00144-8 · Cited by 254
High-dose oral N -acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis
Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., & Herzenberg, L. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511304103 · Cited by 253
Innate immunity in cystic fibrosis lung disease
Hartl, D., Gaggar, A., Bruscia, E., Hector, A., Marcos, V., Jung, A., Greene, C., McElvaney, G., Mall, M., & Döring, G. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.07.003 · Cited by 230
Self-citationPulmonary TH2 response in Pseudomonas aeruginosa–infected patients with cystic fibrosis
Hartl, D., Griese, M., Kappler, M., Zissel, G., Reinhardt, D., Rebhan, C., Schendel, D. J., & Krauss-Etschmann, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.023 · Cited by 208
Self-citationMeyerholz, D. K., Stoltz, D. A., Namati, E., Ramachandran, S., Pezzulo, A. A., Smith, A. R., Rector, M. V., Suter, M. J., Kao, S., McLennan, G., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0643oc · Cited by 202
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Griese, M., Latzin, P., Kappler, M., Weckerle, K., Heinzlmaier, T., Bernhardt, T., & Hartl, D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00047306 · Cited by 198
Self-citationTiringer, K., Treis, A., Fucik, P., Gona, M., Gruber, S., Renner, S., Dehlink, E., Nachbaur, E., Horak, F., Jaksch, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1150oc · Cited by 187
Lai, H.-C., FitzSimmons, S. C., Allen, D. B., Kosorok, M. R., Rosenstein, B. J., Campbell, P. W., & Farrell, P. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421204 · Cited by 179
Clinical Use of Ibuprofen Is Associated with Slower FEV 1 Decline in Children with Cystic Fibrosis
Konstan, M. W., Schluchter, M. D., Xue, W., & Davis, P. B. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-181oc · Cited by 178
Self-citationMeng, Q.-H., Springall, D. R., Bishop, A. E., Morgan, K., Evans, T. J., Habib, S., Gruenert, D. C., Gyi, K. M., Hodson, M. E., Yacoub, M. H., et al. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199803)184:3<323::aid-path2>3.0.co;2-2 · Cited by 178
Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis
Song, Y., Salinas, D., Nielson, D. W., & Verkman, A. S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2005 · Cited by 171
Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis
Paul, K., Rietschel, E., Ballmann, M., Griese, M., Worlitzsch, D., Shute, J., Chen, C., Schink, T., Döring, G., van Koningsbruggen, S., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-959oc · Cited by 168
Kang, J. H., Hwang, S. M., & Chung, I. Y. (2015) · Immunology · doi:10.1111/imm.12352 · Cited by 167
Ordoñez, C. L., Henig, N. R., Mayer-Hamblett, N., Accurso, F. J., Burns, J. L., Chmiel, J. F., Daines, C. L., Gibson, R. L., McNamara, S., Retsch-Bogart, G. Z., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200306-731oc · Cited by 167
Self-citationGehrig, S. M., Duerr, J., Weitnauer, M., Wagner, C. J., Graeber, S. Y., Schatterny, J., Hirtz, S., Belaaouaj, A., Dalpke, A. H., Schultz, C., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-1932oc · Cited by 159
Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling
Nichols, D. P., Chmiel, J. F., & Berger, M. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8039-9 · Cited by 159
Self-citationSaadane, A., Masters, S., DiDonato, J., Li, J., & Berger, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0323oc · Cited by 159
Proteases and antiproteases in chronic neutrophilic lung disease – relevance to drug discovery
Greene, C. M., & McElvaney, N. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00448.x · Cited by 158
Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H., & Arbeit, J. M. (2008) · Blood · doi:10.1182/blood-2007-10-115758 · Cited by 156
Leukotriene B4 Markedly Elevated in the Epithelial Lining Fluid of Patients with Cystic Fibrosis
Konstan, M. W., Walenga, R. W., Hilliard, K. A., & Hilliard, J. B. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_1.896 · Cited by 155
Self-citationMulticenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis
Balfour-Lynn, I. M., Lees, B., Hall, P., Phillips, G., Khan, M. A., Flather, M. D., & Elborn, J. S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1808oc · Cited by 150
Albumin-mediated Regulation of Cellular Glutathione and Nuclear Factor Kappa B Activation
Cantin, A. M., Paquette, B., Richter, M. V., & Larivée, P. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9910106 · Cited by 143
Self-citationAntioxidants in cystic fibrosis
Cantin, A. M., White, T. B., Cross, C. E., Forman, H. J., Sokol, R. J., & Borowitz, D. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.022 · Cited by 143
Self-citationHigh-Dose Ibuprofen in Cystic Fibrosis: Canadian Safety and Effectiveness Trial
Lands, L. C., MILNER, R. A., Cantin, A. M., Manson, D. E., & Corey, M. L. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.04.009 · Cited by 141
Self-citationKonstan, M. W., Döring, G., Heltshe, S. L., Lands, L. C., Hilliard, K. A., Koker, P., Bhattacharya, S., Staab, A., & Hamilton, A. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.12.009 · Cited by 140
Self-citationSagel, S. D., Kapsner, R. K., & Osberg, I. M. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20165 · Cited by 128
Rieber, N. P., Brand, A., Hector, A., Graepler-Mainka, U., Ost, M., Schäfer, I., Wecker, I., Neri, D., Wirth, A., Mays, L., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202144 · Cited by 128
Self-citationIncreased Arginase Activity in Cystic Fibrosis Airways
Grasemann, H., Schwiertz, R., Matthiesen, S., Racké, K., & Ratjen, F. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-253oc · Cited by 127
The role of matrix metalloproteinases in cystic fibrosis lung disease
Gaggar, A., Hector, A., Bratcher, P. E., Mall, M. A., Griese, M., & Hartl, D. (2011) · European Respiratory Journal · doi:10.1183/09031936.00173210 · Cited by 123
Self-citationRatjen, F. A., Saiman, L. M., Mayer-Hamblett, N., Lands, L. C., Kloster, M., Thompson, V., Emmett, P., Marshall, B. C., Accurso, F. J., Sagel, S. D., et al. (2012) · CHEST Journal · doi:10.1378/chest.12-0628 · Cited by 123
IL-10 Attenuates Excessive Inflammation in Chronic Pseudomonas Infection in Mice
Chmiel, J. F., Konstan, M. W., KNESEBECK, J. E., Hilliard, J. B., Bonfield, T. L., Dawson, D. V., & Berger, M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9901043 · Cited by 121
Self-citationDifferent expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases
Lorenz, E., Muhlebach, M. S., Tessier, P. A., Alexis, N. E., Hite, R. D., Seeds, M. C., Peden, D. B., & Meredith, W. J. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.11.011 · Cited by 119
NSP4, an elastase-related protease in human neutrophils with arginine specificity
Perera, N. C., Schilling, O., Kittel, H., Back, W. E., Kremmer, E., & Jenne, D. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200470109 · Cited by 118
Fenretinide Corrects Newly Found Ceramide Deficiency in Cystic Fibrosis
Guilbault, C., Sanctis, J. B. D., Wojewodka, G., Saeed, Z., Lachance, C., Skinner, T. A. A., Vilela, R. M., Kubow, S. J., Lands, L. C., Hajdúch, M., et al. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0036oc · Cited by 118
Gars, M. L., Descamps, D., Roussel, D., Saussereau, E., Guillot, L., Ruffin, M., Tabary, O., Hong, S. S., Boulanger, P. A., Paulais, M., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0875oc · Cited by 117
Chen, J., Kinter, M. T., Shank, S. L., Cotton, C. U., Kelley, T. J., & Ziady, A. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003367 · Cited by 114
Moss, R. B., Mistry, S. J., Konstan, M. W., Pilewski, J. M., Kerem, E., Tal‐Singer, R., & Lazaar, A. L. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.08.016 · Cited by 113
Self-citationOxidant stress suppresses CFTR expression
Cantin, A. M., Bilodeau, G., Ouellet, C., Liao, J., & Hanrahan, J. W. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00070.2005 · Cited by 113
Self-citationInhibition of airway proteases in cystic fibrosis lung disease
Griese, M., Kappler, M., Gaggar, A., & Hartl, D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00146807 · Cited by 112
Self-citationNeutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa
Hirche, T. O., Benabid, R., Deslée, G., Gangloff, S. C., Achilefu, S., Guenounou, M., Lebargy, F., Hancock, R. E. W., & Belaaouaj, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4945 · Cited by 110
Milla, C. E., Chmiel, J. F., Accurso, F. J., VanDevanter, D. R., Konstan, M. W., Yarranton, G. T., Geller, D. E., & for the KB001 Study Group (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22890 · Cited by 109
Self-citationIannitti, R. G., Carvalho, A., Cunha, C., LUCA, A. D., Giovannini, G., Casagrande, A., Zelante, T., Vacca, C., Fallarino, F., Puccetti, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1346oc · Cited by 107
Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease
Pérez-Vilar, J., & Boucher, R. C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.027 · Cited by 105
Conrad, C., Lymp, J. F., Thompson, V., Dunn, C. E., Davies, Z. A., Chatfield, B. A., Nichols, D. P., Clancy, J. P., Vender, R. L., Egan, M. E., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.08.008 · Cited by 104
Trojanek, J., Cobos‐Correa, A., Diemer, S., Kormann, M., Schubert, S. C., Zhou-Suckow, Z., Agrawal, R., Duerr, J., Wagner, C. J., Schatterny, J., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0407oc · Cited by 102
Self-citationCollawn, J. F., & Matalon, S. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00326.2014 · Cited by 100
Velsor, L. W., van Heeckeren, A., & Day, B. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l31 · Cited by 98
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
Lands, L. C., & Stanojevic, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001505.pub4 · Cited by 95
Weldon, S., McNally, P., McAuley, D. F., Oglesby, I. K., Wohlford-Lenane, C., Bartlett, J. A., Scott, C. J., McElvaney, N. G., Greene, C. M., McCray, P. B., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-1986oc · Cited by 94
Innate Immunity Mediated by TLR5 as a Novel Antiinflammatory Target for Cystic Fibrosis Lung Disease
Blohmke, C. J., Victor, R. E., Hirschfeld, A. F., Elias, I. M., Hancock, D. G., Lane, C. R., Davidson, A. G. F., Wilcox, P., Smith, K. D., Overhage, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7764 · Cited by 94
Vandivier, R. W., Richens, T. R., Horstmann, S. A., deCathelineau, A. M., Ghosh, M., Reynolds, S. D., Xiao, Y., Riches, D. W. H., Plumb, J. D., Vachon, E., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00030.2009 · Cited by 92
CFTR-mediated halide transport in phagosomes of human neutrophils
Painter, R. G., Marrero, L., Lombard, G. A., Valentine, V. G., Nauseef, W. M., & Wang, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1009655 · Cited by 92
Impaired Clearance of Apoptotic Cells From Cystic Fibrosis Airways
Vandivier, R. W., Fadok, V. A., Ogden, C. A., Hoffmann, P. R., Brain, J. D., Accurso, F. J., Fisher, J. H., Greene, K. E., & Henson, P. M. (2002) · CHEST Journal · doi:10.1378/chest.121.3_suppl.89s · Cited by 87
Bérubé, J., Roussel, L., Nattagh, L., & Rousseau, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098566 · Cited by 85
Clinical use of dornase alfa is associated with a slower rate of FEV1 decline in cystic fibrosis
Konstan, M. W., Wagener, J. S., Pasta, D. J., Millar, S. J., Jacobs, J. R., Yegin, A., Morgan, W. J., & for the Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21388 · Cited by 82
Self-citationInhalation Treatment with Glutathione in Patients with Cystic Fibrosis. A Randomized Clinical Trial
Griese, M., Kappler, M., Eismann, C., Ballmann, M., Junge, S., Rietschel, E., Koningsbruggen-Rietschel, S. V., Staab, D., Rolinck‐Werninghaus, C., Mellies, U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0427oc · Cited by 81
Self-citationSteagall, W. K., Elmer, H. L., Brady, K. G., & Kelley, T. J. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.1.3789 · Cited by 80
Host-pathogen interplay in the respiratory environment of cystic fibrosis
Yonker, L. M., Cigana, C., Hurley, B. P., & Bragonzi, A. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.02.008 · Cited by 77
Prolonged Inflammatory Response to Acute Pseudomonas Challenge in Interleukin-10 Knockout Mice
Chmiel, J. F., Konstan, M. W., Saadane, A., Krenicky, J. E., Kirchner, H. L., & Berger, M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.8.2107051 · Cited by 77
Self-citationRen, C. L., Pasta, D. J., Rasouliyan, L., Wagener, J. S., Konstan, M. W., & Morgan, W. J. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.07.010 · Cited by 72
Self-citationSwiatecka‐Urban, A., Moreau‐Marquis, S., MacEachran, D. P., Connolly, J. P., Stanton, C. R., Su, J. R., Barnaby, R., O’Toole, G. A., & Stanton, B. A. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00108.2005 · Cited by 72
Redox balance in Cystic Fibrosis
Ziady, A. G., & Hansen, J. M. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.006 · Cited by 71
Blohmke, C. J., Mayer, M. L., Tang, A., Hirschfeld, A. F., Fjell, C. D., Sze, M. A., Falsafi, R., Wang, S. V., Hsu, K., Chilvers, M. A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103661 · Cited by 71
Lamothe, J., & Valvano, M. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/023200-0 · Cited by 69
Decreased expression of peroxisome proliferator activated receptor γ in CFTR−/− mice
Ollero, M., Junaidi, O., Zaman, M. M., Tzameli, I., Ferrando, A. A., Andersson, C., Blanco, P. G., Bialecki, E., & Freedman, S. D. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20020 · Cited by 66
Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study
Grasemann, H., Grasemann, C., Kurtz, F., Tietze-Schillings, G., Vester, U., & Ratjen, F. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00086104 · Cited by 65
Cosgrove, S., Chotirmall, S. H., Greene, C. M., & McElvaney, N. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183863 · Cited by 63
Persistence of Essential Fatty Acid Deficiency in Cystic Fibrosis Despite Nutritional Therapy
Aldamiz-Echevarria, L. J., Prieto, J. A., Andrade, F., Elorz, J., Sojo, A., Lage, S., Sanjurjo, P., Vázquez, C., & Rodríguez‐Soriano, J. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b4e8d3 · Cited by 59
Moss, R. B., Mayer-Hamblett, N., Wagener, J. S., Daines, C. L., Hale, K. A., Ahrens, R. C., Gibson, R. L., ANDERSON, P. J., Retsch‐Bogart, G. Z., Nasr, S. Z., et al. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20152 · Cited by 59
Oral DHA supplementation in ΔF508 homozygous cystic fibrosis patients
Van Biervliet, S., Devos, M., Delhaye, T., Van Biervliet, J. P., Robberecht, E., & Christophe, A. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.12.005 · Cited by 58
Vega-Carrascal, I., Bergin, D. A., McElvaney, O. J., McCarthy, C., Banville, N., Pohl, K., Hirashima, M., Kuchroo, V. K., Reeves, E. P., & McElvaney, N. G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300711 · Cited by 57
Attucci, S., Gauthier, A., Korkmaz, B., Delépine, P., Martino, M., Saudubray, F., Diot, P., & Gauthier, F. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103440 · Cited by 57
Zhang, P.-X., Murray, T. S., Villella, V. R., Ferrari, E., Esposito, S., D’Souza, A. D., Raia, V., Maiuri, L., Krause, D. S., Egan, M. E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201607 · Cited by 56
Peroxisome proliferator-activated receptor-γ in cystic fibrosis lung epithelium
Perez, A., van Heeckeren, A. M., Nichols, D. P., Gupta, S., Eastman, J. F., & Davis, P. B. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90276.2008 · Cited by 55
Kelley, T. J., & Elmer, H. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9560 · Cited by 53
Docosahexaenoic Acid Derivative Prevents Inflammation and Hyperreactivity in Lung
Morin, C., Fortin, S., Cantin, A. M., & Rousseau, É. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0156oc · Cited by 51
Self-citationPotential for antioxidant therapy of cystic fibrosis
Cantin, A. (2004) · Current opinion in pulmonary medicine · doi:10.1097/01.mcp.0000138997.29276.a1 · Cited by 51
Self-citationMechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells
Kraynack, N. C., Corey, D. A., Elmer, H. L., & Kelley, T. J. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2001 · Cited by 50
Risk Factors for Bronchiectasis in Children With Cystic Fibrosis
Sly, P. D., Gangell, C. L., Chen, L., Ware, R. S., Ranganathan, S., Mott, L. S., Murray, C. P. J., & Stick, S. M. (2014) · Survey of Anesthesiology · doi:10.1097/01.sa.0000443983.90197.36 · Cited by 50
Saiman, L. M., Mayer-Hamblett, N., Anstead, M., Lands, L. C., Kloster, M., Goss, C. H., Rose, L. M., Burns, J. L., Marshall, B. C., Ratjen, F. A., et al. (2012) · Pediatric Pulmonology · doi:10.1002/ppul.21601 · Cited by 48
Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype
Kushwah, R., Gagnon, S., & Sweezey, N. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-138 · Cited by 48
The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease
Nichols, D. P., Ziady, A. G., Shank, S. L., Eastman, J. F., & Davis, P. B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00171.2009 · Cited by 45
The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis
Becker, K. A., Riethmüller, J., Zhang, Y., & Gulbins, E. (2010) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401004010039 · Cited by 43
Native Small Airways Secrete Bicarbonate
Shamsuddin, A. K. M., & Quinton, P. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0418oc · Cited by 41
Noah, T. L., Ivins, S. S., Abode, K. A., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21176 · Cited by 39
The Role of Inhaled Corticosteroids in the Management of Cystic Fibrosis
Ross, K. R., Chmiel, J. F., & Konstan, M. W. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911020-00002 · Cited by 37
Self-citationLegendre, C., Mooij, M. J., Adams, C., & O’Gara, F. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.02.005 · Cited by 32
Cathepsin-G Interferes with Clearance of Pseudomonas aeruginosa from Mouse Lungs
Sedor, J., Hogue, L. A., Akers, K. T., Boslaugh, S., Schreiber, J. R., & Ferkol, T. W. (2007) · Pediatric Research · doi:10.1203/01.pdr.0000250043.90468.c2 · Cited by 30
Pass the bicarb: the importance of HCO3– for mucin release
Lisle, R. C. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40598 · Cited by 30
Cooley, J., Sontag, M. K., Accurso, F. J., & Remold‐O’Donnell, E. (2010) · European Respiratory Journal · doi:10.1183/09031936.00073710 · Cited by 29
Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum
Mackerness, K., Jenkins, G. R., Bush, A., & Jose, P. J. (2008) · Thorax · doi:10.1136/thx.2007.089359 · Cited by 28
Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention
Wojewodka, G., Sanctis, J. B. D., & Radzioch, D. (2010) · Journal of Lipids · doi:10.1155/2011/674968 · Cited by 25
Mueller, C., Braag, S. A., Martino, A. T., Tang, Q., Campbell‐Thompson, M., & Flotte, T. R. (2008) · Gene Therapy · doi:10.1038/gt.2008.156 · Cited by 24
Cited by
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Elborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
Neutrophil migration in infection and wound repair: going forward in reverse
de Oliveira, S., Rosowski, E. E., & Huttenlocher, A. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.49 · Cited by 1,058
The role of glutathione reductase and related enzymes on cellular redox homoeostasis network
Couto, N., Wood, J., & Barber, J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.028 · Cited by 1,006
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Metadata
- Authors
- Cantin, A. M., Hartl, D., Konstan, M. W., & Chmiel, J. F.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 14
- Issue
- 4
- Pages
- 419-430
- ISSN
- 1569-1993 (ISSN-L)
- OpenAlex
- W1975572445
- Cited by
- 496
- References
- 139
- FWCI
- 32.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.